Search

everythinglearnresearchcommunity

for

Search:↓

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Acquired Progressive Kinking of Hair is likely an early sign of male pattern baldness.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Alternative treatments show promise for hair growth beyond traditional methods.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Women with acne have lower levels of a specific hormone marker than women without acne.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Some alopecia treatments might help treat COVID-19, but more research is needed.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.